BrainStorm Enters into a Strategic Agreement with Harlan Biotech as It Approaches Clinical Trials for ALS.

Business Wire › September 15, 2009

Linked as:

Extract

BrainStorm Enters into a Strategic Agreement with Harlan Biotech as It Approaches Clinical Trials for ALS.

NEW YORK & PETACH TIKVAH, Israel -- BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into a strategic agreement with Harlan Biotech Israel Ltd (HBI), a leading Good Laboratory Practice cont...

See the full content of this document